Vaccination News

New COVID-19 guidance released by the CDC on Friday indicates that most Americans now live in areas where they can go maskless.

Many older adults and individuals of historically underrepresented groups who experienced a delay in care due to the COVID-19 pandemic still have not received care, according to recent research.

A recent study conducted in Israel identified a potential link between COVID-19 vaccination and sudden sensorineural hearing loss, while a similar study conducted in the U.S. found no significant association.

The CDC’s Advisory Committee on Immunization Practices voted unanimously on Wednesday to recommend a vaccine for tick-borne encephalitis for laboratory workers and people traveling abroad to endemic areas.

Sanofi and GSK announced Wednesday that they will submit data from booster and phase 3 efficacy trials to support authorization of their two-dose protein-based COVID-19 vaccine.

The interval between the first and second doses of the Pfizer-BioNTech and Moderna COVID-19 vaccines can be up to 8 weeks for certain people, the CDC said in updated interim guidance.

Moderna announced Tuesday that it has initiated a phase 3 study of its investigational messenger RNA-based vaccine for RSV.

Last week, Healio provided extensive coverage of the virtual Conference on Retroviruses and Opportunistic Infections.

Healio has launched a new resource that clinicians can use as a tool to guide conversations with patients who are hesitant to receive the COVID-19 vaccine.

Researchers evaluated the immune responses of a few dozen people who received three doses of a COVID-19 messenger RNA vaccine and found, as other have, that a booster shot can protect people infected with a variant from becoming very ill.